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Introduction
While the incidence of sudden cardiac death (SCD) in athletes 
throughout the country is relatively small, ranging from 1:341,551 
participants in high school sports in Minnesota to up to 1:3,100 
male NCAA Division I Basketball players, the emotional impact of 
even one death is devastating not only for the family, but also for 
the town or university [1,2]. Although we have learned a great deal 
regarding the various causes of SCD, the data remain scarce for 
effective preventative measures. The American Heart Association 
(AHA) recommends pre-participation screening, which consists of 
a 12 point history and physical exam [3]. It is not necessary that the 
screening be performed by a physician and the screening has not 
been shown to impact mortality.
We sought to determine whether the addition of focused 
cardiac ultrasound (FCU) with real-time interpretation was a 
feasible addition to pre-participation screening in a multi-purpose 
room setting. Europe and the International Olympic Committee 
have mandated inclusion of screening electrocardiograms in pre-
participation screening, based on the Italian experience in Veneto, 
Italy [4]. This study showed that inclusion of screening ECGs 
decreased the incidence of SCD in Italian athletes by 89% compared 
to non-screened non-athletes [5]. However, the results of the study 
are controversial and have not borne out in Israel or when compared 
to the United States experience [6,7]. A recent cost effectiveness 
projection of the Italian model to high school and college athletes in 
the United States suggests that a 20 year program would save 4,813 
lives at a cost of 10.6-14.4 million dollars per life saved [8]. In addition 
to the financial limitations, widespread ECG usage as a screening 
tool is encumbered by difficulty with interpretation. Furthermore, 
normal or near-normal ECGs can be seen in 10% of patients with 
HCM (false negatives) [9].
The routine performance of an echocardiogram is not mandated, 
except in a relatively few forums. At this point, only 13% of 
professional sports teams incorporate echocardiography, although 
the number is higher for basketball [10]. At the NCAA Division I 
level in football, a group of athletes with a relatively high risk of SCD, 
only 23% of programs responding to a survey reported screening 
echocardiography [11]. Feasibility of full echocardiograms on a mass 
scale is limited by time, space and financial resources.
Development of handheld echocardiography enabling FCU 
could drastically change the role for screening echocardiograms. 
Good concordance of the measurements typically required for the 
diagnosis of hypertrophic cardiomyopathy, as well as assessment of 
valvular regurgitation have been observed between handheld and 
standard echocardiography [12,13]. The most recent guidelines 
on FCU put forth by the American Society of Echocardiography 
incorporate the use of eFCU – defined as FCU performed by an 
experienced echo cardiographer – as a reasonable means by which to 
diagnose hypertrophic cardiomyopathy in an athletic screening [14].
Abstract
Objective: Current American Heart Association (AHA) guidelines 
for pre-participation athletic screening recommend a 12-point 
history and exam to minimize the risk of sudden cardiac death. 
We tested the hypothesis that focused cardiac ultrasound (FCU) 
performed and simultaneously interpreted by a cardiologist using a 
handheld ultrasound device would be a feasible addition.
Methods: We performed pre-participation screening according to 
AHA recommendations on high school athletes in a multi-purpose 
room at their school. In addition to the standard 12-point assessment, 
a cardiologist simultaneously performed and interpreted a FCU on 
each athlete using a handheld ultrasound.
Results: The mean age of the athletes was 16.6 ± 3.4 years; 
68% were male. No evidence of left ventricular hypertrophy, 
cardiomyopathy, bicuspid aortic valve, or aortopathy was identified. 
Coronary ostia could not be visualized. Echocardiography added 
1.35 ± 0.51 minutes to the standard exam.
Conclusion: This feasibility study suggests that the addition of 
handheld echocardiography with real-time interpretation performed 
by a cardiologist to a standard AHA pre-participation screening 
adds less than two minutes of time to the assessment. While the 
study is not as comprehensive as an office based echocardiogram, 
it can provide valuable information which may be useful in ruling 
out some of the most common causes of sudden cardiac death 
in the young athlete or in selecting those who would benefit from 
further testing.
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Methods
Two cardiologists and one cardiology fellow performed a 
pre-participation screening in a multi-purpose room at a public 
high school. Vital signs were obtained by two volunteer registered 
nurses. The standard AHA 12 point pre-participation history and 
physical exams were performed. FCU images were obtained by a 
level II trained cardiologist with a General Electric Vscan handheld 
echocardiogram (GE Healthcare, Wauwatosa, WI). Vscan is a 1.4 × 
7.3 × 2.8cm device weighing 390g with an 8.9cm diagonal, 240 × 320 
pixel display (Figure 1). Vscan uses a phased-array transducer (1.7-
3.8MHz) with a fixed sector angle of 75° and maximum depth of 25 
cm. Color flow Doppler is available within a 30° maneuverable sector. 
Spectral Doppler or M-mode imaging is not available with the device. 
Images are stored on the device as JPEG still captures or MPEG-4 
cine loops.
Subjects lay supine and parasternal long-axis views were obtained 
with and without color Doppler. Short axis views were obtained at 
the level of the aortic valve, mitral valve, papillary muscles and left 
ventricular apex. Apical windows were obtained in subjects with 
prior cardiac history or abnormal physical exam. Abnormal findings 
at point-of-care analysis or off-line analysis would lead to referral of 
the subject to their pediatrician for full evaluation.
Subsequent off-line analysis of the images was performed on 
a Vscan Gateway workstation version 1.0.0.12 (GE Healthcare). 
Measurements of the wall thickness of the interventricular septum 
and posterior wall of the left ventricle were measured, as well as the 
dimensions of the left ventricle. Ejection fraction was also calculated. 
The presence and severity of mitral and aortic regurgitation was 
assessed. The presence of a bicuspid aortic valve was ascertained 
and the diameter of the aortic root was measured. Coronary artery 
origins were not assessed. This protocol was approved by The George 
Washington University Institutional Review Board.
Statistical analysis
Results are expressed as the mean ± standard deviation or as 
absolute values or percentages, as appropriate.
Results
A total of 68 athletes underwent Vscan echocardiography. The 
mean age of the athletes was 16.6 ± 3.4 years and 68% were male. 
The majority of the high school athletes played soccer (41%), followed 
by cross country (21%), cheerleading (13%), volleyball (11%), tennis 
(6.5%), field hockey (4.3%) and golf (2.2%). Echocardiography added 
only 1.35 ± 0.51 minutes to the standard exam. No abnormalities were 
noted real-time by the scanning and interpreting cardiologist (Figure 
2). Subsequent offline analysis showed that the mean thickness 
of the septum and posterior wall were 0.69 ± 0.15cm and 0.72 ± 
0.13cm, respectively. The mean left ventricular internal dimension 
(in diastole) was 4.2 ± 0.48cm. No evidence of left ventricular 
hypertrophy, cardiomyopathy, bicuspid aortic valve, or aortopathy 
was identified on any of the echocardiograms. Coronary ostia could 
not be visualized.
Discussion
The standard AHA screening exam alone is extremely lacking 
in sensitivity. Two recent studies found that screening with history 
and physical alone is associated with a sensitivity of less than 50% 
which is generally considered unacceptable for a screening test 
[15,16]. The addition of an electrocardiogram to the standard exam 
does increase sensitivity (to about 90%), while decreasing specificity 
(from 76.4% and 94.1% to 69.5% and 82.7%, respectively). It is clear 
that while an electrocardiogram may strengthen the effectiveness of 
screening, mass screening requires bulky equipment and can result 
in unnecessary downstream testing in the setting of more frequent 
false positive screening results. When a standard screening and an 
electrocardiogram suggest an abnormality, the next diagnostic test is 
echocardiography. Incorporating the echocardiogram at the outset, 
especially in a high risk population, may be a cost effective solution.
There are limitations to the data acquired by echocardiography. 
First, while hypertrophic cardiomyopathy is the most common 
cause of sudden cardiac death in the young athlete, it is not the only 
cause and a normal echocardiogram may cause false reassurance. In 
addition, cardiovascular exam by FCU is not as complete as standard 
echocardiography, and should not be considered as a replacement. 
FCU does not have the capacity for spectral and tissue Doppler, which 
are crucial for hemodynamic assessment, evaluation of outflow tract 
obstruction and diastolic function. Diastolic function is one of the key 
distinguishing characteristics between a physiologically remodeled 
athlete’s heart and hypertrophic cardiomyopathy. Especially without 
concurrent electrocardiographic testing, we would recommend full 
standard echocardiography for athletes who screen positive based on 
          
Figure 1: Handheld device used to perform focused cardiac ultrasound.
          
Figure 2a: Parasternal long axis view of the heart.
Figure 2b: Short axis view of the heart at the level of the mitral valve.
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the 12 point AHA pre-participation screening or in those with any 
concerning findings on their FCU.
Cost effectiveness is already debated for screening 
electrocardiograms. In our case, the FCU was performed and 
simultaneously interpreted by an experienced cardiologist, 
volunteering with a group of cardiologists without additional costs 
beyond the fixed cost of the device. This fulfills the vision of the FCU 
serving as an extension of the physical exam. The inclusion of the FCU 
could reduce unnecessary downstream testing, as the echocardiogram 
is considered the first evaluation subsequent to an abnormal 
electrocardiogram in pre-participation screening. Currently eFCU 
is a non-reimbursable procedure requiring an expert to volunteer 
time and a device - a possibly insurmountable logistical boundary for 
widespread screening.
Our study demonstrates that it is feasible to incorporate FCU into 
pre-participation screening. It requires very little additional space and 
equipment, and can be done in an ordinary room, adding minimal 
time to the examination. Given that the echocardiogram is so 
frequently performed in downstream testing, immediate performance 
and interpretation of echocardiograms in a mass screening setting 
could add valuable information to the screening process. More 
research is still needed to assess the efficacy and cost effectiveness of 
FCU in the screening of the elite athlete at higher risk for SCD.
References
1. Maron BJ, Haas TS, Ahluwalia A, Rutten-Ramos SC (2013) Incidence of 
cardiovascular sudden deaths in Minnesota high school athletes. Heart 
Rhythm 10: 374-377.
2. Harmon KG, Asif IM, Klossner D, Drezner JA (2011) Incidence of sudden 
cardiac death in National Collegiate Athletic Association athletes. Circulation 
123: 1594-1600.
3. Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, et al. (2007) 
AHA Scientific Statement: Recommendations and Considerations Related to 
Preparticipation Screening for Cardiovascular Abnormalities in Competitive 
Athletes: 2007 Update. A Scientific Statement from the American Heart 
Association Council on Nutrition, Physical Activity, and Metabolism. Circ 115: 
1643-1655. 
4. Corrado D, Pelliccia A, Bjornstad HA, Vanhees L , Biffi A, et al. (2005) 
Cardiovascular pre-participation screening of young competitive athletes for 
prevention of sudden death: proposal for a common European protocol. Eur 
Heart J 26: 516-524. 
5. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, et al. (2006) 
Trends in sudden cardiovascular death in young competitive athletes after 
implementation of a preparticipation screening program. JAMA 296: 1593-
1601. 
6. Steinvil A, Chundadze T, Zeltser D, Rogowski O, Halkin A, et al. (2011) 
Mandatory electrocardiographic screening of athletes to reduce their risk for 
sudden death proven fact or wishful thinking? J Am Coll Cardiol 57: 1291-
1296.
7. Maron BJ, Haas TS, Doerer JJ, Thompson PD, Hodges JS (2009) 
Comparison of U.S. and Italian Experiences With Sudden Cardiac Deaths in 
Young Competitive Athletes and Implications for Preparticipation Screening 
Strategies. Am J Cardiol 104: 276-280. 
8. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO (2009) Sudden 
deaths in young competitive athletes: analysis of 1866 deaths in the United 
States, 1980-2006. Circulation 119: 1085-1092.
9. Halkin A, Steinvil A, Rosso R, Adler A, Rozovski U, et al. (2012) Preventing 
sudden death of athletes with electrocardiographic screening: what is the 
absolute benefit and how much will it cost? J Am Coll Cardiol 60: 2271-2276.
10. Harris KM, Sponsel A, Hutter AM Jr, Maron BJ (2006) Brief communication: 
Cardiovascular screening practices of major North American professional 
sports teams. Ann Intern Med 145: 507-511.
11. Coris EE, Sahebzamani F, Curtis A, Jennings J, Walz SM, et al. (2013) 
Preparticipation cardiovascular screening among National Collegiate Athletic 
Association Division I Institutions. Br J Sports Med 47: 182–184. 
12. Coletta C, De Marchis E, Lenoli M, Rosato S, Renzi M, et al. (2006) Reliability 
of cardiac dimensions and valvular regurgitation assessment by sonographers 
using hand-carried ultrasound devices. Eur J Echocardiogr 7: 275-283.
13. Prinz C, Voigt JU (2011) Diagnostic accuracy of a hand-held ultrasound 
scanner in routine patients referred for echocardiography. J Am Soc 
Echocardiogr 24: 111-116.
14. Spencer KT, Kimura BJ, Korcarz CE, Pellikka PA, Rahko PS, et al. (2013) 
Focused cardiac ultrasound: recommendations from the American Society of 
Echocardiography. J Am Soc Echocardiogr 26: 567-581.
15. Magalski A, McCoy M, Zabel M, Magee LM, Goeke J, et al. (2011) 
Cardiovascular screening with electrocardiography and echocardiography in 
collegiate athletes. Am J Med 124: 511-518.
16. Baggish AL, Hutter AM Jr, Wang F, Yared K, Weiner RB, et al. 
(2010) Cardiovascular screening in college athletes with and without 
electrocardiography: A cross-sectional study. Ann Intern Med 152: 269-275.
